Cargando…
Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma
BACKGROUND: Survivin is a small protein inhibitor of apoptosis and a tumor associated antigen. Survivin expression in multiple myeloma is associated with poor prognosis, disease progression, and drug resistance. The CD4+ response against survivin remains uncharacterized. METHODS: In order to better...
Autores principales: | Locke, Frederick L, Menges, Meghan, Veerapathran, Anandharaman, Coppola, Domenico, Gabrilovich, Dmitry, Anasetti, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437443/ https://www.ncbi.nlm.nih.gov/pubmed/25992291 http://dx.doi.org/10.1186/s40425-015-0065-1 |
Ejemplares similares
-
Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination
por: Galbo, Phillip M., et al.
Publicado: (2017) -
Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer
por: Ryan, B, et al.
Publicado: (2005) -
Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome
por: Fangusaro, J R, et al.
Publicado: (2005) -
Survivin 2α: a novel Survivin splice variant expressed in human malignancies
por: Caldas, Hugo, et al.
Publicado: (2005) -
Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis
por: Miliaraki, Marianna, et al.
Publicado: (2021)